ArticleIJU case reports2026

Significant Response to Nivolumab Plus Ipilimumab in Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report.

Sho Shimasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.